ILCA AC2023: Call for abstracts will open soon!
Call for abstracts opens:
Thursday, 19th January 2023
Help us to shape scientific content to strengthen our community’s knowledge by preparing your submissions on topics:
– Molecular Pathogenesis, Cell Biology and Translational Research
– Epidemiology, Staging and Prognosis
– Surveillance and diagnosis
– Therapy & Miscellaneous & Clinical Trials in progress
Get your submissions ready!
AC2023 Scientific Programme
The ILCA AC 2023 program includes the most relevant topics in the field of liver cancer, both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), from bench-based basic and translational research to bedside clinical management, including up-to-date approaches to early detection and novel therapeutic options.
Sessions will cover recent advances in screening, diagnosis, and treatment, including surgery, locoregional therapies, and systemic immunotherapy and targeted agents for HCC and CCA.
Check out our amazing scientific programme
ILCA Webinar Series 2023
As of 2023, we will increase the webinar offer with a full range of topics delivered by scientific and medical experts exchanging the latest scientific advances and best practices in liver cancer research and care.ILCA’s webinars are ideal for refreshing participants’ knowledge or giving insight into a new aspect in the field of liver cancer.
Webinars Calendar
January 2023 | New IO targets in liver cancer
February 2023 | Benefits and risks of systemic therapy in HCC patients candidates to LT
March 2023 | Targeted therapies and immunotherapy for unresectable BTC/CCA
April 2023 | Liver transplant for CCA
More webinars will offer you in-depth insights on open topics in the field of liver cancer.
Stay tuned for the registration opening!
Discover more
